Adjuvants orchestrate cross-organ induction of mucosal CD8+ T cell immune responses in respiratory tracts
The Journal of Immunology · 2026
DOI: 10.1093/jimmun/vkag117 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Juan Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Immunity, Mucosal, CD8-Positive T-Lymphocytes, Adjuvants, Immunologic, Respiratory System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Mucosal immunity is paramount for combating respiratory infections, but conventional vaccination methods, such as intramuscular injection, often struggle to induce it. Although direct mucosal vaccination is effective, it carries an increased risk of respiratory adverse effects, making it particularly challenging for individuals with chronic respiratory diseases. Consequently, developing a strategy to induce sufficient mucosal immune responses without modifying conventional vaccination methods would be highly desirable. The potential of vaccine adjuvants to facilitate such cross-organ induction of mucosal immunity, given their established role in enhancing and shaping immune responses, is currently not well understood. In this study, we investigated the effects of intramuscular vaccination using OVA or RBD-Fc formulated with four distinct adjuvants, aluminum hydroxide, squalene-based emulsion (AddaVax), STING agonist diamidobenzimidazole (diABZI), and immunostimulatory complexes (ISCOMs). All of these adjuvants increased serum antigen-specific IgG titers and correspondingly elevated IgG levels in bronchoalveolar lavage fluid (BALF), but their impact on mucosal IgA was limited. Interestingly, only ISCOMs significantly increased the proportion of pulmonary antigen-specific CD8+ T cells, a significant amount of which were in a tissue-resident memory phenotype. Subsequent mechanistic investigations showed that ISCOMs-activated dendritic cells promoted the expression of α4β1 integrin on CD8+ T cells, a key factor believed to mediate T cell residency in the lungs. Our findings indicate that judicious adjuvant selection can facilitate the induction of mucosal immune responses via intramuscular vaccination, a well-accepted and safer route.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Spine Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Ji Wang
Zitieren
APA
Jiang, J., Hong, J., Yang, H., Yang, H., Chen, Y., Yu, W., Deng, C., Peng, L., & Wang, J. (2026). Adjuvants orchestrate cross-organ induction of mucosal CD8+ T cell immune responses in respiratory tracts. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag117
Vancouver
Jiang J, Hong J, Yang H, Yang H, Chen Y, Yu W, et al. Adjuvants orchestrate cross-organ induction of mucosal CD8+ T cell immune responses in respiratory tracts. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkag117
BibTeX
@article{Jiang2026,
author = {Jiang, Juan and Hong, Jiacong and Yang, Hao and Yang, Haolan and Chen, Yixin and Yu, Wei and Deng, Caiguanxi and Peng, Lin and Wang, Ji},
title = {Adjuvants orchestrate cross-organ induction of mucosal CD8+ T cell immune responses in respiratory tracts},
journal = {The Journal of Immunology},
year = {2026},
doi = {10.1093/jimmun/vkag117}
}
EUVIMED